Summit Wealth Group’s Amgen AMGN Stock Holding History

Summit Wealth Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-60,438	Closed	–	–	88
2023 Q1	$0	Buy	+60,438	New	+$14.8M	﹤0.01%	159

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Summit Wealth Group's AMGN Position: Q2 2023 in Review

Summit Wealth Group sold out of Amgen (AMGN) in Q2 2023, closing a stake of 60,438 shares.

Summit Wealth Group first reported a position in AMGN in Q1 2023 and held it in 1 quarter. The position peaked at $0 in Q1 2023. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

Summit Wealth Group reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
Summit Wealth Group sold 60,438 Amgen shares in Q2 2023.
Summit Wealth Group first reported a position in Amgen in Q1 2023 and held it in 1 quarter.
Summit Wealth Group's Amgen position peaked at $0 in Q1 2023.
2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Summit Wealth Group's 13F filing for Q2 2023, filed 26 Jul 2023.